Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
The final posts in the new French government won't be filled until after the legislative elections
Read More
As part of its ecological restoration program, the Department of the Environment here in the Principality had installed five "Tide-pool"-type riprap r...
Read More
Bison Futé has classified traffic throughout France as red this Wednesday and Thursday, when many will be leaving for the only long weekend in May....
Read More
The father of British Prime Minister Boris Johnson Stanley, says he is “absolutely delighted” having received confirmation that he has acquired French...
Read More
The first Council of Ministers meeting is taking place today Monday 23rd May,
Read More
